Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pill hopes to ease breathing in tough lung conditions

NCT ID NCT07175038

First seen Sep 30, 2025 · Last updated May 24, 2026 · Updated 35 times

Summary

This study tests an experimental oral drug, ROC-101, in 40 adults with pulmonary arterial hypertension (PAH) or pulmonary hypertension linked to interstitial lung disease (ILD-PH). Participants take the drug alongside their usual care for 24 weeks, with a long-term follow-up. The main goals are to check safety and see if the drug improves blood flow in the lungs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION PAH are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Arizona Pulmonary Specialists

    RECRUITING

    Phoenix, Arizona, 85012, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Bend Memorial Clinic

    RECRUITING

    Bend, Oregon, 97701, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU de BICETRE SERVICE PNEUMOLOGIE

    RECRUITING

    Le Kremlin-Bicêtre, Val-de-Marne, 94275, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • George Washington University Medical

    RECRUITING

    Washington D.C., District of Columbia, 20037, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario 12 de Octubre

    RECRUITING

    Madrid, Madrid, 28041, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • London Health Ontario

    RECRUITING

    London, Ontario, N6A 5W9, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Mayo Clinic of Florida

    RECRUITING

    Jacksonville, Florida, 32224, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Medizinische Hochschule Hannover

    RECRUITING

    Hanover, Lower Saxony, 30625, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ohio State University

    RECRUITING

    Columbus, Ohio, 43210, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Pauls Stradins Clinical University Hospital

    RECRUITING

    Riga, LV-1002, Latvia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Peter Lougheed Centre

    RECRUITING

    Calgary, Alberta, T1Y 6J4, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Royal Prince Alfred Hospital

    RECRUITING

    Camperdown, New South Wales, 2050, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Temple University

    RECRUITING

    Philadelphia, Pennsylvania, 19140, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The University of Kansas Medical Center Research Institute

    RECRUITING

    Kansas City, Kansas, 66160, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of California Davis Health

    RECRUITING

    Rancho Cordova, California, 95670, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Colorado

    RECRUITING

    Aurora, Colorado, 80045, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Michigan

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.